» Articles » PMID: 35516683

Association Between Serum Uric Acid with Diabetes and Other Biochemical Markers

Overview
Specialty Public Health
Date 2022 May 6
PMID 35516683
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aimed to decipher the association between serum uric acid (UA) and glycated hemoglobin (HbA1c) in the population from the southern region of Saudi Arabia.

Method: In this retrospective cross-sectional investigation, clinical data obtained from the different commercial laboratories in the Asir region of Saudi Arabia were screened over 2 years. Data were analyzed using standard statistical methods.

Results: A total of 1984 laboratory investigations with 1215 females (61.2%) and 769 males (38.6%) were included in the data analysis. In our investigation, the prevalence of hyperuricemia in the study population was 53.5% (41.2% females and 12.3% males) and in the diabetic population was 12.7% (9.47% females and 3.23% males), in prediabetics was 12.65% (9.8% females and 2.85% males), respectively. Prediabetic subjects had higher UA levels than people with diabetes or healthy people. Higher UA quartiles were associated with a high level of urea, blood urea nitrogen (BUN) creatinine, HbA1c, fasting blood sugar (FBS), and total cholesterol (TC) ( < 0.05). High UA (OR = 1.33 for diabetes; OR = 2.676 for prediabetes), high BUN (OR = 3.05 for diabetes; OR = 2.293 for prediabetes), high TC (OR = 3.75 for diabetes; OR = 1.098 for prediabetes), and high TG (OR = 2.67 for diabetes; OR = 1.943 for prediabetes) parameters are the most influential risk factor in diabetic and prediabetic patients than the people who have normal UA, BUN, TC, and TG value.

Conclusion: High UA levels are significantly associated with prediabetes as defined by HbA1c criteria, indicating that UA has a significant role in the disturbance of glucose metabolism. A significant positive association was observed between dyslipidemia and serum UA in the study population.

Citing Articles

Hyperuricemia-induced complications: dysfunctional macrophages serve as a potential bridge.

Gu W, Zhao J, Xu Y Front Immunol. 2025; 16:1512093.

PMID: 39935474 PMC: 11810932. DOI: 10.3389/fimmu.2025.1512093.


The interplay of factors in metabolic syndrome: understanding its roots and complexity.

Islam M, Wei P, Suzauddula M, Nime I, Feroz F, Acharjee M Mol Med. 2024; 30(1):279.

PMID: 39731011 PMC: 11673706. DOI: 10.1186/s10020-024-01019-y.


Association of serum uric acid levels with glycated haemoglobin in diabetic patients and healthy controls.

Patel S, Singh M, Kahlon N J Family Med Prim Care. 2024; 13(11):5040-5046.

PMID: 39723005 PMC: 11668416. DOI: 10.4103/jfmpc.jfmpc_777_24.


Lipid profiles and their relation to glycemic control in Saudi Arabia: The role of altitudes and environmental factor.

Alqahtani S J Family Med Prim Care. 2023; 12(7):1352-1360.

PMID: 37649774 PMC: 10465043. DOI: 10.4103/jfmpc.jfmpc_104_23.


Evaluation of levels of uric acid and lipid profile in hospitalized patients with diabetes.

Fayazi H, Mortazavi Khatibani S, Motamed B, Yaseri M BMC Res Notes. 2023; 16(1):154.

PMID: 37488643 PMC: 10367241. DOI: 10.1186/s13104-023-06429-5.


References
1.
LEVINE W, Dyer A, SHEKELLE R, SCHOENBERGER J, Stamler J . Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol. 1989; 42(3):257-67. DOI: 10.1016/0895-4356(89)90061-9. View

2.
Zhou Y, Fang L, Jiang L, Wen P, Cao H, He W . Uric acid induces renal inflammation via activating tubular NF-κB signaling pathway. PLoS One. 2012; 7(6):e39738. PMC: 3382585. DOI: 10.1371/journal.pone.0039738. View

3.
Bandaru P, Shankar A . Association between Serum Uric Acid Levels and Diabetes Mellitus. Int J Endocrinol. 2011; 2011:604715. PMC: 3216382. DOI: 10.1155/2011/604715. View

4.
Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K . Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009; 32(9):1737-42. PMC: 2732137. DOI: 10.2337/dc09-0288. View

5.
Sumino H, Ichikawa S, Kanda T, Nakamura T, Sakamaki T . Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet. 1999; 354(9179):650. DOI: 10.1016/S0140-6736(99)92381-4. View